The Role of Noninvasive 13 C-Octanoate Breath Test in Assessing the Diagnosis of Nonalcoholic Steatohepatitis.

Carmen Fierbinteanu-BraticeviciAna-Maria Calin-NeculaVlad-Teodor Enciu Loredana Goran Anca Mihaela Pantea Stoian Ioan AncutaOctav ViasuAlexandru Constantin Moldoveanu

Published in: Diagnostics (Basel, Switzerland) (2022)

C-OBT had good efficacy for identifying patients with NASH from those with NAFL (steatosis alone) but not those with NAFL from healthy subjects. Considering all these pathogenic steps in NASH we considered that OBT could have the clinical utility to identify patients at risk for NASH, especially "fast progressors".

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
metabolic syndrome
patient reported outcomes
high fat diet induced